HIV seroprevalence in intravenous drug users: Los Angeles, California, 1986. | Zendy

Laurene Mascola | Zendy; Loren Lieb | Zendy; K A Iwakoshi | Zendy; David McAllister | Zendy; T Siminowski | Zendy; Madison Giles | Zendy; Grace Run | Zendy; Shirley L. Fannin | Zendy; Irma H. Strantz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HIV seroprevalence in intravenous drug users: Los Angeles, California, 1986.

Author(s) -

Laurene Mascola,

Loren Lieb,

K A Iwakoshi,

David McAllister,

T Siminowski,

Madison Giles,

Grace Run,

Shirley L. Fannin,

Irma H. Strantz

Publication year - 1989

Publication title -

american journal of public health

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.284

H-Index - 264

eISSN - 1541-0048

pISSN - 0090-0036

DOI - 10.2105/ajph.79.1.81

Subject(s) - seroprevalence , intravenous drug , medicine , human immunodeficiency virus (hiv) , needle sharing , methadone , methadone maintenance , demography , environmental health , viral disease , immunology , antibody , psychiatry , serology , syphilis , sociology , condom

To estimate the seroprevalence and investigate risk behaviors for HIV (human immunodeficiency virus) infection in intravenous drug users in Los Angeles County, a stratified, random sample of 790 clients, enrolled in either methadone maintenance or detoxification programs, were studied. Thirteen study participants (1.8 per cent) were seropositive; of these, five were homosexual/bisexual males and three were female prostitutes. Ninety-five per cent of all participants reported sharing needles. Risk reduction education efforts must be expanded before the HIV antibody prevalence rate increases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research